Rechercher | Pikumil

Akshay Gorde Ajouter une nouvelle offre d'emploi Health
2026-09-23 17:08:33 -

Gaucher Disease Drugs Market Growth In-Depth Analysis, Size, Outlook Up Analysis By Fact.MR
ROCKVILLE, MARYLAND , Sept 23, 2026 – The Gaucher disease drugs market reached USD 2.4 billion in 2025 and is projected to stand at USD 2.5 billion in 2026. It is forecast to expand to USD 4.3 billion by 2036, recording a compound annual growth rate (CAGR) of 5.5% from 2026 to 2036. This absolute opportunity of USD 1.8 billion by 2036 is concentrated in enzyme replacement therapy...

0 Commentaires 0 Parts 32 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Riya Patil Ajouter une nouvelle offre d'emploi Autre
2026-08-31 09:35:27 -

Gaucher Disease Drugs Market Outlook: Treatment Innovation and Industry Trends
Gaucher disease is a rare inherited metabolic disorder and the most common lysosomal storage disorder. The condition results from genetic mutations that reduce the production or activity of glucocerebrosidase, causing certain fatty substances to accumulate in organs and tissues. Growing awareness of rare diseases, improvements in diagnosis, increasing healthcare investments, and advances in...

0 Commentaires 0 Parts 171 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Divya Sawant Ajouter une nouvelle offre d'emploi Health
2026-08-07 10:00:58 -

Why the Gaucher Disease Drugs Market Is Set for Steady Growth Through 2034
Gaucher disease is a rare inherited lysosomal storage disorder caused by the deficiency of the enzyme glucocerebrosidase, resulting in the accumulation of fatty substances in organs such as the liver, spleen, bone marrow, and lungs. The condition can lead to enlarged organs, anemia, bone complications, and reduced quality of life if left untreated. Growing awareness of rare diseases,...

0 Commentaires 0 Parts 189 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!